25 XP   0   0   10

Tff Pharmaceuticals Inc
Buy, Hold or Sell?

Let's analyse Tff Pharmaceuticals Inc together

PenkeI guess you are interested in Tff Pharmaceuticals Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Tff Pharmaceuticals Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Tff Pharmaceuticals Inc

I send you an email if I find something interesting about Tff Pharmaceuticals Inc.

Quick analysis of Tff Pharmaceuticals Inc (30 sec.)










What can you expect buying and holding a share of Tff Pharmaceuticals Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.29
Expected worth in 1 year
$-0.13
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
$-0.42
Return On Investment
-6.4%

For what price can you sell your share?

Current Price per Share
$6.59
Expected price per share
$4.55 - $9.78
How sure are you?
50%

1. Valuation of Tff Pharmaceuticals Inc (5 min.)




Live pricePrice per Share (EOD)

$6.59

Intrinsic Value Per Share

$-0.81 - $-0.54

Total Value Per Share

$-0.52 - $-0.26

2. Growth of Tff Pharmaceuticals Inc (5 min.)




Is Tff Pharmaceuticals Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$13.6m$28m-$11.7m-71.7%

How much money is Tff Pharmaceuticals Inc making?

Current yearPrevious yearGrowGrow %
Making money-$5.9m-$8.6m$2.6m45.3%
Net Profit Margin0.0%21,209,038.1%--

How much money comes from the company's main activities?

3. Financial Health of Tff Pharmaceuticals Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#651 / 1031

Most Revenue
#809 / 1031

Most Profit
#492 / 1031

Most Efficient
#262 / 1031

What can you expect buying and holding a share of Tff Pharmaceuticals Inc? (5 min.)

Welcome investor! Tff Pharmaceuticals Inc's management wants to use your money to grow the business. In return you get a share of Tff Pharmaceuticals Inc.

What can you expect buying and holding a share of Tff Pharmaceuticals Inc?

First you should know what it really means to hold a share of Tff Pharmaceuticals Inc. And how you can make/lose money.

Speculation

The Price per Share of Tff Pharmaceuticals Inc is $6.59. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tff Pharmaceuticals Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tff Pharmaceuticals Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.29. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.29 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tff Pharmaceuticals Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-1.4%-0.17-2.5%-0.42-6.4%-0.32-4.8%-0.30-4.6%
Usd Book Value Change Per Share-0.05-0.8%-0.10-1.6%-0.29-4.5%-0.01-0.2%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.05-0.8%-0.10-1.6%-0.29-4.5%-0.01-0.2%0.010.2%
Usd Price Per Share0.35-0.64-6.22-5.30-5.05-
Price to Earnings Ratio-0.94--0.94--3.91--3.53--3.36-
Price-to-Total Gains Ratio-6.89-1.49--20.84--10.31--10.31-
Price to Book Ratio1.21-1.37-5.65-3.53-3.36-
Price-to-Total Gains Ratio-6.89-1.49--20.84--10.31--10.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.59
Number of shares151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.10-0.01
Usd Total Gains Per Share-0.10-0.01
Gains per Quarter (151 shares)-15.84-1.74
Gains per Year (151 shares)-63.35-6.95
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-63-730-7-17
20-127-1360-14-24
30-190-1990-21-31
40-253-2620-28-38
50-317-3250-35-45
60-380-3880-42-52
70-443-4510-49-59
80-507-5140-56-66
90-570-5770-63-73
100-633-6400-69-80

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.019.00.05.0%1.020.00.04.8%1.020.00.04.8%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.014.01.025.0%6.014.01.028.6%6.014.01.028.6%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.021.00.0%0.00.021.00.0%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.014.01.025.0%6.014.01.028.6%6.014.01.028.6%

Fundamentals of Tff Pharmaceuticals Inc

About Tff Pharmaceuticals Inc

TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company's drug candidates are TFF Voriconazole Inhalation Powder, which is in Phase II clinical trials for the treatment of invasive pulmonary aspergillosis; and TFF Tacrolimus Inhalation Powder, which is in Phase II clinical trials used to prevent lung transplant rejection. It is also developing other dry powder products, such as Augmenta monoclonal antibodies for the treatment of COVID-19 therapeutics; TFF Niclosamide, which is completed Phase 1 clinical trials for the treatment of COVID-19 disease; and other vaccines. TFF Pharmaceuticals, Inc. has a license agreement with the University of Texas at Austin for the development of inhaled dry powder drugs; a joint development agreement with Augmenta Bioworks, Inc. to develop Augmenta monoclonal antibodies; a licensing and collaboration agreement with UNION therapeutics A/S; and a collaborative research and development agreement with the National Institute of Environmental Health Sciences to develop dry powder formulations of hyaluronan to prevent and treat respiratory diseases. The company was incorporated in 2018 and is headquartered in Fort Worth, Texas.

Fundamental data was last updated by Penke on 2024-03-22 05:27:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Tff Pharmaceuticals Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Tff Pharmaceuticals Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tff Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21,209,038.1%-21,209,038.1%
TTM-5Y-10,782,783.6%+10,782,783.6%
5Y-10,782,783.6%10Y-10,269,317.7%-513,465.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY21,209,038.1%-262.1%+21,209,300.2%
5Y-10,782,783.6%-455.6%-10,782,328.0%
10Y-10,269,317.7%-589.0%-10,268,728.7%
1.1.2. Return on Assets

Shows how efficient Tff Pharmaceuticals Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • -29.6% Return on Assets means that Tff Pharmaceuticals Inc generated $-0.30 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tff Pharmaceuticals Inc:

  • The MRQ is -29.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -33.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-29.6%TTM-33.8%+4.1%
TTM-33.8%YOY-29.2%-4.6%
TTM-33.8%5Y-22.0%-11.8%
5Y-22.0%10Y-21.2%-0.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-29.6%-12.5%-17.1%
TTM-33.8%-12.2%-21.6%
YOY-29.2%-11.2%-18.0%
5Y-22.0%-13.4%-8.6%
10Y-21.2%-14.7%-6.5%
1.1.3. Return on Equity

Shows how efficient Tff Pharmaceuticals Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • -32.2% Return on Equity means Tff Pharmaceuticals Inc generated $-0.32 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tff Pharmaceuticals Inc:

  • The MRQ is -32.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -36.8%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-32.2%TTM-36.8%+4.5%
TTM-36.8%YOY-32.3%-4.4%
TTM-36.8%5Y-24.1%-12.6%
5Y-24.1%10Y-23.0%-1.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-32.2%-15.8%-16.4%
TTM-36.8%-15.7%-21.1%
YOY-32.3%-13.9%-18.4%
5Y-24.1%-18.3%-5.8%
10Y-23.0%-19.2%-3.8%

1.2. Operating Efficiency of Tff Pharmaceuticals Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Tff Pharmaceuticals Inc is operating .

  • Measures how much profit Tff Pharmaceuticals Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tff Pharmaceuticals Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY21,307,453.5%-21,307,453.5%
TTM-5Y-12,045,427.4%+12,045,427.4%
5Y-12,045,427.4%10Y-11,471,835.6%-573,591.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY21,307,453.5%-279.7%+21,307,733.2%
5Y-12,045,427.4%-459.9%-12,044,967.5%
10Y-11,471,835.6%-596.9%-11,471,238.7%
1.2.2. Operating Ratio

Measures how efficient Tff Pharmaceuticals Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tff Pharmaceuticals Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-213,074.535+213,074.535
TTM-5Y120,451.200-120,451.200
5Y120,451.20010Y114,715.429+5,735.771
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-213,074.5353.615-213,078.150
5Y120,451.2005.560+120,445.640
10Y114,715.4297.396+114,708.033

1.3. Liquidity of Tff Pharmaceuticals Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Tff Pharmaceuticals Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.54 means the company has $9.54 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tff Pharmaceuticals Inc:

  • The MRQ is 9.538. The company is very able to pay all its short-term debts. +2
  • The TTM is 10.742. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.538TTM10.742-1.204
TTM10.742YOY12.228-1.486
TTM10.7425Y20.030-9.288
5Y20.03010Y19.499+0.531
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5383.986+5.552
TTM10.7424.440+6.302
YOY12.2285.552+6.676
5Y20.0306.158+13.872
10Y19.4996.492+13.007
1.3.2. Quick Ratio

Measures if Tff Pharmaceuticals Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Quick Ratio of 8.83 means the company can pay off $8.83 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tff Pharmaceuticals Inc:

  • The MRQ is 8.833. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.525. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.833TTM9.525-0.692
TTM9.525YOY11.444-1.920
TTM9.5255Y19.171-9.647
5Y19.17110Y18.259+0.913
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8333.638+5.195
TTM9.5254.168+5.357
YOY11.4445.515+5.929
5Y19.1716.012+13.159
10Y18.2596.209+12.050

1.4. Solvency of Tff Pharmaceuticals Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Tff Pharmaceuticals Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tff Pharmaceuticals Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.08 means that Tff Pharmaceuticals Inc assets are financed with 8.0% credit (debt) and the remaining percentage (100% - 8.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tff Pharmaceuticals Inc:

  • The MRQ is 0.080. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.080. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.080TTM0.080+0.001
TTM0.080YOY0.091-0.012
TTM0.0805Y0.078+0.001
5Y0.07810Y0.080-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0800.335-0.255
TTM0.0800.330-0.250
YOY0.0910.267-0.176
5Y0.0780.367-0.289
10Y0.0800.378-0.298
1.4.2. Debt to Equity Ratio

Measures if Tff Pharmaceuticals Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 8.7% means that company has $0.09 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tff Pharmaceuticals Inc:

  • The MRQ is 0.087. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.087. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.087TTM0.087+0.000
TTM0.087YOY0.102-0.015
TTM0.0875Y0.088-0.001
5Y0.08810Y0.084+0.004
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0870.376-0.289
TTM0.0870.398-0.311
YOY0.1020.334-0.232
5Y0.0880.429-0.341
10Y0.0840.476-0.392

2. Market Valuation of Tff Pharmaceuticals Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tff Pharmaceuticals Inc generates.

  • Above 15 is considered overpriced but always compare Tff Pharmaceuticals Inc to the Biotechnology industry mean.
  • A PE ratio of -0.94 means the investor is paying $-0.94 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tff Pharmaceuticals Inc:

  • The EOD is -17.726. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.941. Based on the earnings, the company is expensive. -2
  • The TTM is -0.939. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.726MRQ-0.941-16.785
MRQ-0.941TTM-0.939-0.003
TTM-0.939YOY-3.909+2.971
TTM-0.9395Y-3.529+2.591
5Y-3.52910Y-3.361-0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.726-2.643-15.083
MRQ-0.941-2.418+1.477
TTM-0.939-2.742+1.803
YOY-3.909-4.123+0.214
5Y-3.529-6.257+2.728
10Y-3.361-6.478+3.117
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tff Pharmaceuticals Inc:

  • The EOD is -25.938. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.378. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.187. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-25.938MRQ-1.378-24.561
MRQ-1.378TTM-1.187-0.191
TTM-1.187YOY-5.051+3.864
TTM-1.1875Y-5.420+4.233
5Y-5.42010Y-5.162-0.258
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-25.938-3.244-22.694
MRQ-1.378-2.939+1.561
TTM-1.187-3.478+2.291
YOY-5.051-5.592+0.541
5Y-5.420-8.473+3.053
10Y-5.162-8.881+3.719
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Tff Pharmaceuticals Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.21 means the investor is paying $1.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tff Pharmaceuticals Inc:

  • The EOD is 22.836. Based on the equity, the company is expensive. -2
  • The MRQ is 1.213. Based on the equity, the company is underpriced. +1
  • The TTM is 1.368. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD22.836MRQ1.213+21.623
MRQ1.213TTM1.368-0.155
TTM1.368YOY5.650-4.282
TTM1.3685Y3.525-2.157
5Y3.52510Y3.358+0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD22.8362.124+20.712
MRQ1.2132.041-0.828
TTM1.3682.118-0.750
YOY5.6502.915+2.735
5Y3.5253.682-0.157
10Y3.3584.114-0.756
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tff Pharmaceuticals Inc.

3.1. Institutions holding Tff Pharmaceuticals Inc

Institutions are holding 14.737% of the shares of Tff Pharmaceuticals Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Carlson Capital LP8.20010.1089193960-1040-0.5333
2023-12-31DRW Securities, LLC1.69110.00444000000
2023-12-31Vanguard Group Inc1.4321033873-2-0.0059
2023-12-31AIGH Capital Management, LLC1.24640.081929482-76727-72.2415
2023-12-31Geode Capital Management, LLC0.6646015720557454.9379
2023-12-31Renaissance Technologies Corp0.48610.000111497527784.8392
2023-12-31BlackRock Inc0.36050852740.0469
2023-12-31Westside Investment Management, Inc.0.3440.014681366392366.5138
2023-09-30Newbridge Financial Services Group, Inc.0.01060.00116250125025
2023-12-31UBS Group AG0.076601813-1856-50.586
2023-12-31Tower Research Capital LLC0.0580.00011372817147.2072
2023-12-31JPMorgan Chase & Co0.045201070106853400
2023-09-30Cutler Group LP0.00170100000
2023-12-31University Of Texas Investment Mgmt Co0.03730.0025882-1-0.1133
2023-12-31ORG Partners LLC0.03130.000974000
2023-12-31Venturi Wealth Management, LLC0.0140.0002330-1-0.3021
2023-12-31Royal Bank of Canada0.013103093090
2023-12-31Bank of America Corp0.0039092-8-8
2023-12-31Wells Fargo & Co0.0033077-33-30
2023-12-31HM Payson & Co0.002506000
Total 14.72240.2147355190-58977-16.6%

3.2. Funds holding Tff Pharmaceuticals Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.0450.00012661600
2024-01-31Vanguard Total Stock Mkt Idx Inv0.951502250700
2024-01-31Fidelity Extended Market Index0.52820.00021249300
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.45450.00011075000
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.010306067-556622-98.9218
2024-01-31Fidelity Series Total Market Index0.1098025961623166.8037
2024-01-31Fidelity Total Market Index0.04780113000
2023-12-31Northern Trust Extended Eq Market Idx0.04330.0001102500
2023-12-31NT Ext Equity Mkt Idx Fd - L0.04330.0001102500
2023-12-31BlackRock Extended Equity Market K0.03920.0001928-2-0.2151
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.0360.000185200
2024-02-29iShares Core S&P Total US Stock Mkt ETF0.0308072800
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.0290.000168510.1462
2023-12-31BlackRock U.S. Equity Market F0.0215050900
2024-01-31Spartan Total Market Index Pool E0.0193045700
2024-01-31Fidelity Nasdaq Composite Index0.018042600
2024-01-31Vanguard U.S. Eq Idx £ Acc0.0158037400
2024-01-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.0103024300
2024-01-31Spartan Extended Market Index Pool E0.00980.000123100
2024-01-31State St US Extended Mkt Indx NL Cl C0.0091021600
Total 2.47250.00189858-555000-617.6%

3.3. Insider Transactions

Insiders are holding 5.012% of the shares of Tff Pharmaceuticals Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-08-15Carlson Capital L PSELL860011
2023-08-15Harlan F WeismanBUY240006.25
2023-08-15Stephen RocamboliBUY8006.25
2023-08-15Zamaneh MikhakBUY48006.25

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Tff Pharmaceuticals Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.051-0.105+107%-0.293+478%-0.012-77%0.014-469%
Book Value Per Share--0.2890.462-38%1.106-74%1.152-75%1.122-74%
Current Ratio--9.53810.742-11%12.228-22%20.030-52%19.499-51%
Debt To Asset Ratio--0.0800.080+1%0.091-12%0.078+3%0.080+1%
Debt To Equity Ratio--0.0870.087+1%0.102-15%0.088-1%0.084+4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.093-0.167+80%-0.422+354%-0.315+239%-0.302+225%
Free Cash Flow Per Share---0.064-0.142+124%-0.316+397%-0.209+230%-0.201+217%
Free Cash Flow To Equity Per Share--0.044-0.022+149%-0.312+812%0.121-64%0.113-61%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.545--------
Intrinsic Value_10Y_min---0.809--------
Intrinsic Value_1Y_max---0.844--------
Intrinsic Value_1Y_min---0.830--------
Intrinsic Value_3Y_max---1.935--------
Intrinsic Value_3Y_min---1.860--------
Intrinsic Value_5Y_max---2.300--------
Intrinsic Value_5Y_min---2.187--------
Market Cap15587590.600-7%16604592.55022471592.631-26%157973157.513-89%122317845.285-86%116493185.985-86%
Net Profit Margin----0%212090.381-100%-107827.8360%-102693.1770%
Operating Margin----0%213074.535-100%-120454.2740%-114718.3560%
Operating Ratio----0%-213074.5350%120451.200-100%114715.429-100%
Pb Ratio22.836+95%1.2131.368-11%5.650-79%3.525-66%3.358-64%
Pe Ratio-17.726-1783%-0.941-0.9390%-3.909+315%-3.529+275%-3.361+257%
Price Per Share6.590+95%0.3500.639-45%6.223-94%5.304-93%5.052-93%
Price To Free Cash Flow Ratio-25.938-1783%-1.378-1.187-14%-5.051+267%-5.420+293%-5.162+275%
Price To Total Gains Ratio-129.818-1783%-6.8951.487-564%-20.842+202%-10.306+49%-10.306+49%
Quick Ratio--8.8339.525-7%11.444-23%19.171-54%18.259-52%
Return On Assets---0.296-0.338+14%-0.292-1%-0.220-26%-0.212-29%
Return On Equity---0.322-0.368+14%-0.323+0%-0.241-25%-0.230-29%
Total Gains Per Share---0.051-0.105+107%-0.293+478%-0.012-77%0.014-469%
Usd Book Value--13690929.00016348938.500-16%28071269.500-51%26580633.850-48%25755104.095-47%
Usd Book Value Change Per Share---0.051-0.105+107%-0.293+478%-0.012-77%0.014-469%
Usd Book Value Per Share--0.2890.462-38%1.106-74%1.152-75%1.122-74%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.093-0.167+80%-0.422+354%-0.315+239%-0.302+225%
Usd Free Cash Flow---3013324.000-4929019.000+64%-8015093.250+166%-5030779.700+67%-4828419.619+60%
Usd Free Cash Flow Per Share---0.064-0.142+124%-0.316+397%-0.209+230%-0.201+217%
Usd Free Cash Flow To Equity Per Share--0.044-0.022+149%-0.312+812%0.121-64%0.113-61%
Usd Market Cap15587590.600-7%16604592.55022471592.631-26%157973157.513-89%122317845.285-86%116493185.985-86%
Usd Price Per Share6.590+95%0.3500.639-45%6.223-94%5.304-93%5.052-93%
Usd Profit---4409244.000-5925474.318+34%-8610119.500+95%-5514877.114+25%-5280131.299+20%
Usd Revenue----0%23856.790-100%4775.167-100%4547.778-100%
Usd Total Gains Per Share---0.051-0.105+107%-0.293+478%-0.012-77%0.014-469%
 EOD+3 -5MRQTTM+18 -11YOY+18 -145Y+11 -2010Y+10 -21

4.2. Fundamental Score

Let's check the fundamental score of Tff Pharmaceuticals Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-17.726
Price to Book Ratio (EOD)Between0-122.836
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.833
Current Ratio (MRQ)Greater than19.538
Debt to Asset Ratio (MRQ)Less than10.080
Debt to Equity Ratio (MRQ)Less than10.087
Return on Equity (MRQ)Greater than0.15-0.322
Return on Assets (MRQ)Greater than0.05-0.296
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Tff Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.045
Ma 20Greater thanMa 507.728
Ma 50Greater thanMa 1006.643
Ma 100Greater thanMa 2006.933
OpenGreater thanClose6.350
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets14,885
Total Liabilities1,194
Total Stockholder Equity13,691
 As reported
Total Liabilities 1,194
Total Stockholder Equity+ 13,691
Total Assets = 14,885

Assets

Total Assets14,885
Total Current Assets10,893
Long-term Assets3,992
Total Current Assets
Cash And Cash Equivalents 9,726
Net Receivables 361
Other Current Assets 806
Total Current Assets  (as reported)10,893
Total Current Assets  (calculated)10,893
+/-0
Long-term Assets
Property Plant Equipment 2,204
Long-term Assets Other 8
Long-term Assets  (as reported)3,992
Long-term Assets  (calculated)2,211
+/- 1,781

Liabilities & Shareholders' Equity

Total Current Liabilities1,142
Long-term Liabilities52
Total Stockholder Equity13,691
Total Current Liabilities
Short-term Debt 83
Accounts payable 983
Total Current Liabilities  (as reported)1,142
Total Current Liabilities  (calculated)1,066
+/- 76
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt52
Long-term Liabilities  (as reported)52
Long-term Liabilities  (calculated)52
+/-0
Total Stockholder Equity
Common Stock59
Retained Earnings -113,569
Accumulated Other Comprehensive Income -204
Other Stockholders Equity 127,405
Total Stockholder Equity (as reported)13,691
Total Stockholder Equity (calculated)13,691
+/-0
Other
Capital Stock59
Cash and Short Term Investments 9,726
Common Stock Shares Outstanding 47,442
Current Deferred Revenue76
Liabilities and Stockholders Equity 14,885
Net Debt -9,591
Net Invested Capital 13,691
Net Working Capital 9,751
Property Plant and Equipment Gross 2,204
Short Long Term Debt Total 135



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-30
> Total Assets 
10,402
10,402
8,322
13,804
11,033
29,187
26,590
22,534
43,158
38,662
61,354
57,154
49,302
40,698
33,783
27,913
20,227
24,120
18,212
13,569
14,885
14,88513,56918,21224,12020,22727,91333,78340,69849,30257,15461,35438,66243,15822,53426,59029,18711,03313,8048,32210,40210,402
   > Total Current Assets 
10,274
10,274
8,177
13,659
10,571
29,187
26,590
22,534
42,213
37,559
59,776
55,457
47,492
38,838
31,524
25,182
16,979
19,025
13,960
9,416
10,893
10,8939,41613,96019,02516,97925,18231,52438,83847,49255,45759,77637,55942,21322,53426,59029,18710,57113,6598,17710,27410,274
       Cash And Cash Equivalents 
10,262
10,262
8,146
13,632
10,551
28,095
25,731
21,924
41,618
35,301
58,055
52,067
44,716
33,795
26,414
20,890
13,147
16,612
12,216
7,663
9,726
9,7267,66312,21616,61213,14720,89026,41433,79544,71652,06758,05535,30141,61821,92425,73128,09510,55113,6328,14610,26210,262
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
1,421
1,943
2,595
2,945
2,808
2,762
187
189
284
361
3612841891872,7622,8082,9452,5951,9431,42100000000000
       Other Current Assets 
0
12
0
27
20
1,092
859
610
595
2,258
1,721
1,969
834
2,448
2,164
1,484
1,070
2,226
1,555
1,468
806
8061,4681,5552,2261,0701,4842,1642,4488341,9691,7212,2585956108591,09220270120
   > Long-term Assets 
0
128
0
145
462
106
0
0
945
1,103
1,577
1,697
1,810
1,860
2,259
2,731
3,248
5,095
4,251
4,154
3,992
3,9924,1544,2515,0953,2482,7312,2591,8601,8101,6971,5771,1039450010646214501280
       Property Plant Equipment 
0
0
0
0
0
0
0
0
945
1,103
1,577
1,697
1,810
1,860
2,259
2,564
3,241
3,274
2,404
2,316
2,204
2,2042,3162,4043,2743,2412,5642,2591,8601,8101,6971,5771,10394500000000
       Intangible Assets 
0
0
0
0
0
106
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000010600000
       Long-term Assets Other 
0
128
0
145
462
0
0
0
0
0
0
0
0
0
0
167
8
1,821
8
8
8
8881,8218167000000000046214501280
> Total Liabilities 
1,157
1,157
1,360
1,624
2,188
1,543
1,205
690
1,573
1,322
1,817
1,534
1,558
1,961
2,197
3,974
2,205
1,241
1,668
1,287
1,194
1,1941,2871,6681,2412,2053,9742,1971,9611,5581,5341,8171,3221,5736901,2051,5432,1881,6241,3601,1571,157
   > Total Current Liabilities 
1,157
1,157
1,360
1,624
2,188
411
1,205
690
1,573
1,322
1,817
1,534
1,558
1,961
2,197
3,828
2,077
1,131
1,577
1,215
1,142
1,1421,2151,5771,1312,0773,8282,1971,9611,5581,5341,8171,3221,5736901,2054112,1881,6241,3601,1571,157
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79
80
81
81
82
83
838281818079000000000000000
       Accounts payable 
429
429
410
385
691
411
1,205
690
1,573
1,298
1,817
1,509
1,558
1,494
2,029
3,480
1,634
920
1,344
1,007
983
9831,0071,3449201,6343,4802,0291,4941,5581,5091,8171,2981,5736901,205411691385410429429
       Other Current Liabilities 
728
728
950
1,239
1,497
0
0
0
0
24
0
25
0
417
168
347
363
4
0
0
0
000436334716841702502400001,4971,239950728728
   > Long-term Liabilities 
0
429
0
385
691
1,132
1,205
690
1,573
1,322
1,817
1,534
1,558
1,544
2,197
146
128
110
92
72
52
5272921101281462,1971,5441,5581,5341,8171,3221,5736901,2051,13269138504290
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
146
128
110
92
72
52
527292110128146000000000000000
       Other Liabilities 
0
0
0
0
0
1,132
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000001,13200000
> Total Stockholder Equity
-3,241
9,245
6,962
12,181
8,844
27,645
25,385
21,845
41,585
37,340
59,537
55,620
47,745
38,737
31,586
23,940
18,023
22,879
16,543
12,282
13,691
13,69112,28216,54322,87918,02323,94031,58638,73747,74555,62059,53737,34041,58521,84525,38527,6458,84412,1816,9629,245-3,241
   Common Stock
4
4
4
4
4
18
19
19
22
23
25
25
25
25
25
25
26
36
36
36
59
5936363626252525252525232219191844444
   Retained Earnings -113,569-109,160-104,140-97,088-89,715-82,441-73,694-65,318-55,269-46,590-41,934-34,280-28,384-23,326-19,510-15,712-11,050-8,212-6,025-3,842-3,842
   Capital Surplus 
0
597
497
694
206
43,339
44,896
0
0
71,648
101,535
102,302
103,158
104,079
105,257
106,462
0
0
0
0
0
00000106,462105,257104,079103,158102,302101,53571,6480044,89643,3392066944975970
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
0
13,083
0
20,388
19,891
43,339
44,896
45,192
70,015
71,648
101,535
102,302
103,158
104,079
105,257
106,462
107,923
120,071
120,805
121,571
127,405
127,405121,571120,805120,071107,923106,462105,257104,079103,158102,302101,53571,64870,01545,19244,89643,33919,89120,388013,0830



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-23,907
Operating Income-23,907-23,907
 
Operating Expense (+$)
Research Development13,223
Selling General Administrative11,616
Selling And Marketing Expenses-
Operating Expense23,90724,839
 
Net Interest Income (+$)
Interest Income168
Interest Expense--
Other Finance Cost-0
Net Interest Income168
 
Pretax Income (+$)
Operating Income-23,907
Net Interest Income168
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-23,854-23,907
EBIT - interestExpense = 0
-23,854
-23,854
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--23,854
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-23,854
Tax Provision--
Net Income From Continuing Ops-23,854-23,854
Net Income-23,854
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--168
 

Technical Analysis of Tff Pharmaceuticals Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tff Pharmaceuticals Inc. The general trend of Tff Pharmaceuticals Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tff Pharmaceuticals Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tff Pharmaceuticals Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 9.75 < 9.75 < 9.78.

The bearish price targets are: 5.23 > 4.55.

Tweet this
Tff Pharmaceuticals Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tff Pharmaceuticals Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tff Pharmaceuticals Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tff Pharmaceuticals Inc. The current macd is 0.10105189.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tff Pharmaceuticals Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Tff Pharmaceuticals Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Tff Pharmaceuticals Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tff Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) ChartTff Pharmaceuticals Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tff Pharmaceuticals Inc. The current adx is 32.13.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Tff Pharmaceuticals Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Tff Pharmaceuticals Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tff Pharmaceuticals Inc. The current sar is 10.24.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tff Pharmaceuticals Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tff Pharmaceuticals Inc. The current rsi is 44.04. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Tff Pharmaceuticals Inc Daily Relative Strength Index (RSI) ChartTff Pharmaceuticals Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tff Pharmaceuticals Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Tff Pharmaceuticals Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Tff Pharmaceuticals Inc Daily Stochastic Oscillator ChartTff Pharmaceuticals Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tff Pharmaceuticals Inc. The current cci is -145.06411518.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tff Pharmaceuticals Inc Daily Commodity Channel Index (CCI) ChartTff Pharmaceuticals Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tff Pharmaceuticals Inc. The current cmo is -21.7504456.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tff Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) ChartTff Pharmaceuticals Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tff Pharmaceuticals Inc. The current willr is -84.64491363.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tff Pharmaceuticals Inc Daily Williams %R ChartTff Pharmaceuticals Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tff Pharmaceuticals Inc.

Tff Pharmaceuticals Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tff Pharmaceuticals Inc. The current atr is 1.08692022.

Tff Pharmaceuticals Inc Daily Average True Range (ATR) ChartTff Pharmaceuticals Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tff Pharmaceuticals Inc. The current obv is -1,025,845.

Tff Pharmaceuticals Inc Daily On-Balance Volume (OBV) ChartTff Pharmaceuticals Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tff Pharmaceuticals Inc. The current mfi is 59.31.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Tff Pharmaceuticals Inc Daily Money Flow Index (MFI) ChartTff Pharmaceuticals Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tff Pharmaceuticals Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-12CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-02CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Tff Pharmaceuticals Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tff Pharmaceuticals Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.045
Ma 20Greater thanMa 507.728
Ma 50Greater thanMa 1006.643
Ma 100Greater thanMa 2006.933
OpenGreater thanClose6.350
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Tff Pharmaceuticals Inc with someone you think should read this too:
  • Are you bullish or bearish on Tff Pharmaceuticals Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tff Pharmaceuticals Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tff Pharmaceuticals Inc

I send you an email if I find something interesting about Tff Pharmaceuticals Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Tff Pharmaceuticals Inc.

Receive notifications about Tff Pharmaceuticals Inc in your mailbox!